CBMG - Cellular Biomedicine Group Inc.

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201612/31/201512/31/2014
Total Revenue627.932,505.423564.377
Cost of Revenue860.4171,880.331242.215
Gross Profit-232.487625.092322.162
Operating Expenses
Research Development11,475.5877,573.2283,146.499
Selling General and Administrative12,095.54613,777.4068,190.307
Non Recurring4,611.714123.4281,427.84
Others---
Total Operating Expenses---
Operating Income or Loss-28,415.334-20,848.97-12,442.484
Income from Continuing Operations
Total Other Income/Expenses Net211.051672.64887.025
Earnings Before Interest and Taxes-28,204.283-20,176.322-12,355.459
Interest Expense---
Income Before Tax-28,204.283-20,176.322-12,355.459
Income Tax Expense4.093-728.601-
Minority Interest---
Net Income From Continuing Ops-28,208.376-19,447.721-12,355.459
Non-recurring Events
Discontinued Operations---3,119.152
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-28,208.376-19,447.721-15,474.611
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-28,208.376-19,447.721-15,474.611